Arthur Caplan reports on a closed-door meeting at the Vatican, where Church leadership made it clear it will continue to throw its ethical might and even its money into the debate about where to get stem cells and how best to study them.
The left ventricular assist device that will keep blood pumping through Dick Cheney’s veins for the rest of his life would not have been invented if not for government-funded R&D at the National Institutes of Health.
The FDA’s myopic focus on early-stage testing and lack of emphasis on phase four human clinical trials has led to many safety-related drug recalls in recent years, meriting a reexamination of our regulatory system.
Recent investigations into performance-enhancing drug use in professional sports has driven debate over the substances in the public square. But when making decisions about steroids, one size does not fit all, and there’s more to consider than just “did he or didn’t he?”
A team at the Oregon National Primate Research Center in Beaverton, Oregon has succeeded in cloning twenty macaque monkey embryos. The techniques they used to achieve this monumental breakthrough in cloning work should also work for making human embryos. Could this breakthrough pave the way to a new source for embryonic stem cells?
Science Progress and American Progress's Doing What Works project teamed up to produce a set of policy proposals that the Obama administration and Congress can adopt to reinvest in the building blocks of American science, innovation, and economic competitiveness. Read the overview of the five reports.
What We Believe
Science Progress proceeds from the propositions that scientific inquiry is among the finest expressions of human excellence, that it is a crucial source of human flourishing, a critical engine of economic growth, and must be dedicated to the common good. Scientific inquiry entails global responsibilities. It should lead to a more equitable, safer, and healthier future for all of humankind.